Related Experiment Video
Updated: Aug 16, 2025

06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
13.2K
TGF-β Pathways Stratify Colorectal Cancer into Two Subtypes with Distinct Cartilage Oligomeric Matrix Protein (COMP)
Jia-Tong Ding1,2, Hao-Nan Zhou1,3, Ying-Feng Huang1
1Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Biomolecules
|December 23, 2022
Summary
Cartilage oligomeric matrix protein (COMP) is a key gene for predicting colorectal cancer (CRC) subtypes. This finding offers new avenues for TGFβ-targeted therapies and clinical decision-making in CRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Colorectal cancers (CRCs) are a major global cause of cancer mortality.
- The molecular characteristics of TGF-β pathway-inducing CRCs are not fully understood.
Purpose of the Study:
- To identify molecular features distinguishing TGF-β pathway-inducing colorectal cancer subtypes.
- To discover novel biomarkers for CRC subtype prediction and potential therapeutic targets.
Main Methods:
- Unsupervised hierarchical clustering and weighted gene co-expression network analysis were used to stratify CRC samples.
- A machine learning algorithm integrating LASSO, XGBoost, and random forest regression identified key genes.
- Bioinformatic analyses focused on COMP-related immune infiltration and functions.
Main Results:
- The integrated machine learning approach identified COMP as a crucial hub gene.
- COMP demonstrated significant predictive value for CRC subtypes (AUC = 0.91).
- COMP is upregulated in various cancers, particularly advanced CRCs, and influences immune infiltration (M2 macrophages, cancer-associated fibroblasts).
Conclusions:
- COMP serves as a reliable signature for CRC subtype prediction.
- These findings offer a new target for TGFβ-targeted anticancer drugs.
- The results can aid in clinical decision-making for CRC patients.
Related Concept Videos
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K

